H. pylori eradication in NSAID-associated ulcers

Drug and Therapeutics Bulletin

Volumn 43, Issue 5, 2005, Pages 37-40

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; DICLOFENAC; LANSOPRAZOLE; METRONIDAZOLE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; TETRACYCLINE;

ARTICLE; CLINICAL TRIAL; CONFIDENCE INTERVAL; DIGESTIVE SYSTEM ULCER; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG RESPONSE; DRUG WITHDRAWAL; DYSPEPSIA; ERADICATION THERAPY; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; INFECTION CONTROL; LOW DRUG DOSE; PEPTIC ULCER BLEEDING; PROBABILITY; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; ULCER HEALING;

EID: 18744383972     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.2005.43537     Document Type: Article

References (18)

1. Harvey RF et al. Randomised controlled trial of effects of Helicobacter pylori infection and its eradication on heartburn and gastro-oesophageal reflux: Bristol helicobacter project. BMJ 2004; 328: 1417-9.
2. Scotttish Intercollegiate Guideline Network, 2003. Dyspepsia. A national clinical guideline [online]. Available: http://www.sign.ac.uk/pdf/sign68.pdf [Accessed 21 April 2005].
3. Ford A et al. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patents. The Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD003840.pub2. DOI: 10.1002/14651858.CD003840.pub2.
4. Gisbert JP et al. H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. The Cochrane Database of Systematic Reviews 2004, Issue 2. Art. No.: CD004062.pub2. DOI: 10.1002/14651858.CD004062.pub2.
5. Taking stock of coxibs. DTB 2005; 43: 1-6.
6. Laine L. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs - nice or necessary? Rev Gashoenterol Disord 2004; 4 (suppl 4): S33-41.
7. Sørensen HT et al. Risk of upper gastrointestinal bleeding associated with use of low-dose aspirin. Am J Gastroenterol 2000; 95: 2218-24.
8. Huang J-Q et al. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet 2002; 359: 14-22.
9. Chan FK et al. Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet 1997; 350: 975-9.
10. Labenz J et al. Primary prevenfion of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial. Gut 2002; 51: 329-35.
11. Chan FK et al. Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet 2002; 359: 9-13.
12. Chan FK et al. Does eradication of Helicobacter pylori impair healing of nonsteroidal anti-inflammatory drug associated bleeding peptic ulcers? A prospective randomized study. Aliment Pharmacol Ther 1998; 12: 1201-5.
13. Bianchi Porro G et al. Role of Helicobacter pylori in ulcer healing and recurrence of gastric and duodenal ulcers in longterm NSAID users. Response to omeprazole dual therapy. Gut 1996; 39: 22-6.
14. Hawkey CJ et al. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Lancet 1998; 352: 1016-21.
15. Laine L et al. Stratifying the risk of NSAID-related upper gastrointestinal clinical events: results of a double-blind outcomes study in patients with rheumatoid arthritis. Gastroenterology 2002; 123: 1006-12.
16. Chan FK et al. Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen. N Engl J Med 2001; 344: 967-73.
17. Lanas A et al. Helicobacter pylori increases the risk of upper gastrointestinal bleeding in patients taking low-dose aspirin. Aliment Pharmacol Ther 2002; 16: 779-86.
18. Lai KC et al. Lansoprazole for the prevention of recurrences of ulcer complications from long-term low-dose aspirin use. N Engl J Med 2002; 346: 2033-8.